Get the Stockscreener App
71.73
0.52%
0.37
After Hours:
72.80
1.07
+1.49%
Solventum Corp stock is traded at $71.73, with a volume of 780.50K.
It is up +0.52% in the last 24 hours and down -7.91% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
See More
Previous Close:
$71.36
Open:
$71.08
24h Volume:
780.50K
Relative Volume:
0.86
Market Cap:
$12.41B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
33.21
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
-4.04%
1M Performance:
-7.91%
6M Performance:
-3.15%
1Y Performance:
+23.54%
1-Day Range:
$70.63
$72.33
1-Week Range:
$70.63
$74.76
52-Week Range:
$54.26
$85.92
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
71.73 | 12.35B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
483.12 | 172.46B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
176.37 | 51.09B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.87 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
279.20 | 39.87B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
What institutional investors are buying Solventum Corporation stockMarket Forecast Recommendation With Low Risk - jammulinksnews.com
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Stock Analysis | Solventum OutlookTechnical Weakness and Analyst Disagreement Cloud Near-Term Prospects - AInvest
Building trade automation scripts for Solventum CorporationReal Trader Watchlist of Hot Stocks Released - metal.it
Why Solventum Corporation stock attracts strong analyst attentionDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™. - GlobeNewswire Inc.
What makes Solventum Corporation stock price move sharplyTarget Return Focused Trade Insights Shared - beatles.ru
What are the latest earnings results for Solventum CorporationOutstanding risk-reward balance - jammulinksnews.com
Is it the right time to buy Solventum Corporation stockBuild wealth with reliable stock picks - jammulinksnews.com
How many analysts rate Solventum Corporation as a “Buy”Discover high-impact stocks for growth - jammulinksnews.com
When is Solventum Corporation stock expected to show significant growthTrack high-yield stocks before they peak - jammulinksnews.com
Assessing the Strategic and Financial Implications of 3M's Spin-Off of Solventum - AInvest
3M Company: Adjusting to Solventum Spinoff and MMM Stock Performance - AInvest
3M Company: Still Adjusting To Spinoff Of Solventum (NYSE:MMM) - Seeking Alpha
What are Solventum Corporation company’s key revenue driversExceptional return forecasts - jammulinksnews.com
What to Expect From Solventum's Q2 2025 Earnings Report - MSN
Solventum Corporation Stock Analysis and ForecastConsistently high yield - PrintWeekIndia
Solventum Corporation's Anticipated Q2 2025 Earnings ReleaseNews and Statistics - IndexBox
What To Expect From Solventum's Q2 2025 Earnings Report - Barchart.com
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - StreetInsider
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Nasdaq
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - MSN
Earnings Alert: Solventum Sets Q2 2025 Report Date, Management to Discuss Future Outlook - Stock Titan
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):